Thursday, April 3, 2025
Home Tags Ctxr

Tag: ctxr

Citius Pharma
2020 Watch List

Citius Pharma (CTXR) On The Move.

Editor / Curator -
Biotech News

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double...

Editor / Curator -
All News

Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus...

Editor / Curator -
Superbug News - CoronaVirus Watch List

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and...

Editor / Curator -
Aphex Biocleanse, Superbug Stock Review
All News

Oh, No. Alcohol-Based Sanitizers Losing Effectiveness Against Superbugs.

Editor / Curator -
All News

VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market...

Editor / Curator -
Biotech News

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Editor / Curator -
Citius, Biotech Stock Review
Biotech News

Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal...

Editor / Curator -
Biotech News

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Editor / Curator -
Immunomedics, Biotech Stock Review
All News

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in...

Editor / Curator -
1234Page 3 of 4

Latest article

Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

2025 Watch List Editor / Curator -
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

All News Editor / Curator -
Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday...

Zomedica (ZOMDF) Surges 40% Higher, Friday.

All News Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.